Ketorolac Tromethamine Injection, Solution
Product Images NDC 63323-162

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 63323-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ket0m 0004 01

Ket0m 0004 01
Chemical structure of Ketorolac Tromethamine, showing its distinctive molecular framework including a pyrrolizine skeleton bonded to a carboxylic acid group and the tromethamine moiety with three hydroxymethyl groups.*
FDA Label Image

Ket0m 0004 02

FDA Label Image

Ket0m 0004 03

Ket0m 0004 03
Label of Ketorolac Tromethamine injection solution by Fresenius Kabi USA, LLC, showing the company name and contact information in Lake Zurich, IL, including a website and phone number for more information.*
FDA Label Image

Ket0m 0004 04

Ket0m 0004 04
Label for Ketorolac Tromethamine Injection, USP 15 mg per mL in a 1 mL single-dose vial for intramuscular or intravenous use. The label shows the NDC 63323-161-00 and indicates the product is Rx only, marketed by Fresenius Kabi USA, LLC. It instructs to see the package insert for usual dosage information.*
FDA Label Image

Ket0m 0004 05

Ket0m 0004 05
Label for Ketorolac Tromethamine Injection, USP 15 mg per mL. The vial contains 1 mL single dose for intramuscular or intravenous use. The label highlights usual dosage instructions directing to the package insert and shows the labeler as Fresenius Kabi USA, LLC. The NDC number 63323-161-00 is also visible.*
FDA Label Image

Ket0m 0004 06

Ket0m 0004 06
Label for Ketorolac Tromethamine Injection, USP 15 mg per mL, presented as single dose vials with 25 x 1 mL quantity. The label states the product is for intramuscular or intravenous use and includes storage conditions of 20° to 25°C. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL. Contains detailed ingredient and usage information with a barcode.*
FDA Label Image

Ket0m 0004 07

Ket0m 0004 07
The label for Ketorolac Tromethamine Injection, USP, 30 mg per mL, supplied as a 1 mL single dose vial. It is indicated for intramuscular or intravenous use, labeled by Fresenius Kabi USA, LLC. The label includes the NDC code 63323-162-00 and notes Rx only.*
FDA Label Image

Ket0m 0004 08

Ket0m 0004 08
Label for Ketorolac Tromethamine Injection, USP, 30 mg per mL in a 1 mL single dose vial. It indicates the product is for intramuscular or intravenous use, with usual dosage directions to see the package insert. The label includes the NDC 63323-162-00 and the maker Fresenius Kabi USA, LLC.*
FDA Label Image

Ket0m 0004 09

Ket0m 0004 09
Label for Ketorolac Tromethamine Injection, USP 30 mg per mL, single dose vials of 1 mL, 25 count. Intended for intramuscular or intravenous use. The label includes storage instructions and manufacturer information for Fresenius Kabi USA, LLC in Lake Zurich, IL.*
FDA Label Image

Ket0m 0004 10

Ket0m 0004 10
Label for Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL) in a 2 mL single dose vial. The label specifies use for intramuscular injection only and not for intravenous use. Manufactured by Fresenius Kabi USA, LLC. Includes barcode and lot/expiration information.*
FDA Label Image

Ket0m 0004 11

Ket0m 0004 11
Label for Ketorolac Tromethamine Injection, USP at 60 mg per 2 mL (30 mg per mL) strength. The product is a 2 mL single dose vial intended for intramuscular use only, not for intravenous use. It is labeled by Fresenius Kabi USA, LLC and marked Rx only with dosage instructions referring to the package insert.*
FDA Label Image

Ket0m 0004 12

Ket0m 0004 12
Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL) in single dose vials. The label specifies use for intramuscular injection only and not for intravenous use. The package contains 25 vials of 2 mL each. The label includes storage conditions and manufacturer information for Fresenius Kabi USA, LLC, Lake Zurich, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.